Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.39 -0.18 (5.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.57 | 52 Week High | $16.89 | |||
| Open | $3.52 | 52 Week Low | $7.35 | |||
| Day High | $3.54 | P/E | N/A | |||
| Day Low | $3.39 | EPS | $-2.35 | |||
| Volume | 184,235 | |||||
